The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer.
 
David Matthew Kurtz
Stock and Other Ownership Interests - Foresight Diagnostics
Consulting or Advisory Role - Genentech; Roche Molecular Diagnostics
Patents, Royalties, Other Intellectual Property - Dr. Kurtz has patents pending related to methods for analysis of cell free nucleic acids and methods for treatment selection based on statistical frameworks of clinical outcome.
 
Jacob J. Chabon
Employment - Foresight Diagnostics
Leadership - Foresight Diagnostics
Stock and Other Ownership Interests - Foresight Diagnostics
Patents, Royalties, Other Intellectual Property - Patent applications related to detection of circulating tumor DNA
 
Brian Sworder
Stock and Other Ownership Interests - Allogene Therapeutics
Patents, Royalties, Other Intellectual Property - Dr. Sworder has a patent pending related to methods of resistance to immunotherapy for lymphoma.
 
Lyron Co Ting Keh
No Relationships to Disclose
 
Joanne Soo
No Relationships to Disclose
 
Stefan Alig
No Relationships to Disclose
 
Andre Schultz
Employment - Unimed (I)
Stock and Other Ownership Interests - 10X Genomics; GlaxoSmithKline
 
Andrea Garofalo
No Relationships to Disclose
 
Emily G. Hamilton
No Relationships to Disclose
 
Binbin Chen
No Relationships to Disclose
 
Mari Olsen
No Relationships to Disclose
 
Everett James Moding
Consulting or Advisory Role - DeciBio
 
Chih Long Liu
No Relationships to Disclose
 
Ash A. Alizadeh
Leadership - Lymphoma Research Foundation
Stock and Other Ownership Interests - CAPP Medical; CiberMed; Forty Seven
Honoraria - Janssen Oncology; Janssen Oncology; Roche
Consulting or Advisory Role - Celgene; Cibermed; Foresight Diagnostics; Foresight Diagnostics; Foresight Diagnostics; Gilead Sciences; Roche/Genentech
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University. (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Maximilian Diehn
Stock and Other Ownership Interests - CiberMed; Foresight Diagnostics
Consulting or Advisory Role - AstraZeneca; BioNTech; Genentech; Gritstone Bio; Illumina; Novartis; Reflexion Medical; Roche
Research Funding - Illumina; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Varian Medical Systems